603014 Stock Overview

Shandong Weigao Blood Purification Products Co., Ltd. More details

603014 fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	3/6
Financial Health	5/6
Dividends	0/6

Rewards

Price-To-Earnings ratio (24.7x) is below the CN market (37.8x)

Earnings grew by 40.4% over the past year

Risk Analysis

Shares are highly illiquid

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Shandong Weigao Blood Purification Products Co., Ltd. Competitors

Shantou Institute of Ultrasonic Instrument

SZSE:301602

CN¥10.6b

Shandong Weigao Orthopaedic Device

SHSE:688161

CN¥10.4b

Guangzhou Wondfo BiotechLtd

SZSE:300482

CN¥10.3b

Sinocare

SZSE:300298

CN¥12.0b

Price History & Performance

Summary of share price highs, lows and changes for Shandong Weigao Blood Purification Products
Historical stock prices
Current Share Price	CN¥26.50
52 Week High	CN¥0
52 Week Low	CN¥0
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	0%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	603014	CN Medical Equipment	CN Market
7D	n/a	0.6%	0.7%
1Y	n/a	-11.5%	7.4%

Return vs Industry: Insufficient data to determine how 603014 performed against the CN Medical Equipment industry.

Return vs Market: Insufficient data to determine how 603014 performed against the CN Market.

Price Volatility

Is 603014's price volatile compared to industry and market?
603014 volatility
603014 Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	6.4%
Market Average Movement	7.0%
10% most volatile stocks in CN Market	10.4%
10% least volatile stocks in CN Market	4.3%

Stable Share Price: 603014's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: Insufficient data to determine 603014's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2004	3,568	Cunming Zhang	www.wego-healthcare.com

Shandong Weigao Blood Purification Products Co., Ltd. engages in the research and development, production, and sale of blood purification medical products in China. It offers dialyzers, dialysis machines, hemodialysis machines, A.V. fistula needle sets, extracorporeal blood circuits, bloodlines, and plasma separators; peritoneal dialysis (PD) solutions; and PD consumables, such as bag free set, catheter joints, and transfer tube sets.

Shandong Weigao Blood Purification Products Co., Ltd. Fundamentals Summary

How do Shandong Weigao Blood Purification Products's earnings and revenue compare to its market cap?
603014 fundamental statistics
Market cap	CN¥10.90b
Earnings (TTM)	CN¥442.07m
Revenue (TTM)	CN¥3.53b

24.7x

P/E Ratio

3.1x

P/S Ratio

Is 603014 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
603014 income statement (TTM)
Revenue	CN¥3.53b
Cost of Revenue	CN¥1.88b
Gross Profit	CN¥1.65b
Other Expenses	CN¥1.21b
Earnings	CN¥442.07m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	1.07
Gross Margin	46.78%
Net Profit Margin	12.52%
Debt/Equity Ratio	0.1%

How did 603014 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/16 05:21
End of Day Share Price	2025/05/16 00:00
Earnings	2023/12/31
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Shandong Weigao Blood Purification Products Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.